Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Rheumatology | Musculoskeletal | Immunology | Family Medicine
Disease Category: Osteoarthritis
Location: United States, OK

Clinical Trial Details

Overview

Research Study Summary

Do you suffer from knee pain due to osteoarthritis? If so, you may be eligible to take part in a clinical study testing the effectiveness of an investigational drug in treating knee pain due to osteoarthritis.

Purpose

A randomized, double-blind clinical study wants to test the effectiveness of a pain medicine in order to treat knee pain due to osteoarthritis.

Patients cannot take part in the study if they have any previous diagnosis of psychosis, bipolar disorder, schizoaffective disorder or have a history of substance abuse or dependence within the past year, excluding nicotine and caffeine.

Patients must be at least 40 years of age and meet the American College of Rheumatology clinical and radiographic criteria for the diagnosis of OA of the knee with pain for at least 14 days per month for 3 months prior to study entry.

Your participation in this study is expected to last up to 15 weeks after screening is complete. Up to 230 subjects will be participating in this study at about 27 study sites in the United States.

Compensation for participation includes $31 per visit (up to a total of $186.00) to reimburse for transportation, parking, meal, or other expenses related to the study.

Patient Inclusion Criteria

  • Patients must be at least 40 years with pain in the knee(s) for at least 14 days of each month for 3 months prior to study entry.
  • Clinical diagnosis of osteoarthritis osteophytes with radiographic evidence and one of the following: >50 yrs or <30 minutes morning stiffness or Crepitus.
  • Patient cannot have received intrarticular hyaluranoate or steroids, joint lavage, or invasive treatment to the index knee in past 6 months.
  • No knee arthoscopy of index knee within past year.
  • Subject must also be ambulatory

Patient Exclusion Criteria

  • Patient will be excluded from the study if any of the following criteria apply:
  • Have received treatment within the last 30 days with a drug that has not received regulatory approval for any indication at the time of study entry.
  • Have any previous diagnosis of psychosis, bipolar disorder, or schizoaffective disorder.
  • Have major depressive disorder as determined using depression module of the Mini International Neuropsychiatric Interview (MINI).
  • Have a history of substance abuse or dependence within the past year, excluding nicotine and caffeine.

For more information,

To Learn more
Phase

3

Gender

Both Male and Female

Age

40 and up

Overall Status

Recruiting

Duration

15 Weeks

Facility Type

N/A

Compensation

$31 to $186

Contact

Rachel Waldrop, Director of Clinical Research
Health Research Institute
1044 S.W. 44th Street, Suite 403
Oklahoma City, OK 73109
Phone: 405-616-4888
Fax: 405-616-4885

View Map

Research Center Information: Health Research Institute

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 95895

Date Last Changed: July 25, 2013


DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.